Video

Q&A With Richard Lewis, MD, FAAN, of Cedars Sinai: Taking the Next Steps in CIDP Treatment

Author(s):

As more is learned about the diagnosis and treatment of CIDP the medical community is also learning how best to work with patients with the condition.

As more is learned about the diagnosis and treatment of CIDP the medical community is also learning how best to work with patients with the condition.

There are mechanisms in place to monitor treatment success but Richard Lewis, MD, from Cedars Sinai said it is important to have people familiar with the condition to monitor patient health in order to assure them the best possible outcome. Lewis spoke during the American Academy of Neurology's annual meeting in Washington DC. 

Related Videos
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
A. Sidney Barritt, MD | Credit: UNC School of Medicine
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
© 2024 MJH Life Sciences

All rights reserved.